These 3 activities review the role of the gut microbiome in C. difficile infection, discuss evidence-based guidelines for treatment and prevention of recurrent infection, and describe emerging restoration approaches that reduce complications and improve clinical outcomes.

This activity will cover topics on the diagnosis, treatment, and management of patients with chronic fibrosing ILD and CF-ILD patients who have contracted COVID-19.Free live webinar on Thursday, October 1, 2020 3:00 PM – 4:15 PM EDT

Free live webinar occurring on Saturday, September 19, 2020 10:00 AM and Tuesday, September 29, 2020 1:00 PM This activity will cover topics on the diagnosis, treatment, and management of patients with multiple myeloma.

This activity is intended for allergists, immunologists, and other clinicians involved in the diagnosis and treatment of patients with severe asthma.

Glaucoma is a heterogeneous group of diseases that has become a major cause of irreversible blindness worldwide.

In this case-based activity, Dr. Harrison Farber takes learners through the differential diagnosis and treatment of two cardiopulmonary patients. Discussion topics include differential diagnostic procedures, guideline recommendations, and therapy selection.

Explain the role of non-statin therapies in cardiovascular risk management. Summarize the mechanism of action, efficacy, and safety of novel agents for LDL-C and ASCVD risk reduction

Characterize current intraocular agents used to treat glaucoma according to efficacy, safety, and preservative content